These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 37065429)

  • 1. Bisphosphonates as Potential Inhibitors of Calcification in Bioprosthetic Heart Valves (Review).
    Timchenko TP
    Sovrem Tekhnologii Med; 2022; 14(2):68-78. PubMed ID: 37065429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption.
    Price PA; Faus SA; Williamson MK
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):817-24. PubMed ID: 11348880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.
    Lomashvili KA; Monier-Faugere MC; Wang X; Malluche HH; O'Neill WC
    Kidney Int; 2009 Mar; 75(6):617-25. PubMed ID: 19129793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticalcification and antiresorption effects of bisacylphosphonates.
    Van Gelder JM; Breuer E; Ornoy A; Schlossman A; Patlas N; Golomb G
    Bone; 1995 May; 16(5):511-20. PubMed ID: 7654466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates prevent experimental vascular calcification: Treat the bone to cure the vessels?
    Persy V; De Broe M; Ketteler M
    Kidney Int; 2006 Nov; 70(9):1537-8. PubMed ID: 17051257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates and atherosclerosis: why?
    Bevilacqua M; Dominguez LJ; Rosini S; Barbagallo M
    Lupus; 2005; 14(9):773-9. PubMed ID: 16218486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of the bisphosphonates.
    Fleisch H
    Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stumble-from pipe cleaner to bone builder.
    Swislocki AL; Wexler JA
    Endocr Pract; 2007; 13(2):194-7. PubMed ID: 17490936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic use of bisphosphonates.
    Compston JE
    BMJ; 1994 Sep; 309(6956):711-5. PubMed ID: 7950525
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental basis for the use of bisphosphonates in Paget's disease of bone.
    Fleisch H
    Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the chemistry and biological activity of the bisphosphonates.
    Ebetino FH; Hogan AM; Sun S; Tsoumpra MK; Duan X; Triffitt JT; Kwaasi AA; Dunford JE; Barnett BL; Oppermann U; Lundy MW; Boyde A; Kashemirov BA; McKenna CE; Russell RG
    Bone; 2011 Jul; 49(1):20-33. PubMed ID: 21497677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bisphosphonates for vascular calcification].
    Tanaka Y; Okada Y
    Clin Calcium; 2007 Mar; 17(3):386-90. PubMed ID: 17339743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages.
    Roelofs AJ; Thompson K; Ebetino FH; Rogers MJ; Coxon FP
    Curr Pharm Des; 2010; 16(27):2950-60. PubMed ID: 20722616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?
    Neven EG; De Broe ME; D'Haese PC
    Kidney Int; 2009 Mar; 75(6):580-2. PubMed ID: 19247382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates: mechanisms of action and clinical use in osteoporosis--an update.
    Fleisch H
    Horm Metab Res; 1997 Mar; 29(3):145-50. PubMed ID: 9137986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of chitosan microspheres containing bisphosphonates.
    Patashnik S; Rabinovich L; Golomb G
    J Drug Target; 1997; 4(6):371-80. PubMed ID: 9239577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemistry of bisphosphonates: from antiscaling agents to clinical therapeutics.
    Widler L; Jahnke W; Green JR
    Anticancer Agents Med Chem; 2012 Feb; 12(2):95-101. PubMed ID: 21864230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates: structure-activity relations from a clinical perspective.
    Papapoulos SE
    Medicina (B Aires); 1997; 57 Suppl 1():61-4. PubMed ID: 9567357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the Mechanism of Action and Use of Bisphosphonates in Horses.
    Yocom A; Contino E; Kawcak C
    J Equine Vet Sci; 2023 Aug; 127():104503. PubMed ID: 37120118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.